Myocardial infarction test kit

creatine kinaseserumplasma

5 tests/box, 25 tests/box, 40 tests/box, 100 tests/box Certificates: CE, SGS ISO13485, ISO9001 Matching Equipments: Solid Phase Fluorescence Immunoassay System Manufactured by Guangzhou KOFA Biotechnology Co.,Ltd. Intended Use: This reagent kit is base on fluorescent chromatographic technology, supporting the quantitative rapid test of CK-MB level in the serum/plasma, and CK-MB is the marker for the early diagnosis of acute myocardial infraction (AMI) The advantages of KOFA CK-MB 1. Advanced fluoroimmunoassay quantitative testing platform, make accurate and quantitative rapid test of CK-MB level available 2. Low cost and rapid test, can get the quantitative and reliable results in 15 minutes, shorten the testing turnaround time. 3. The testing results from KOFA CK-MB has good correlation with that of Roche diagnostics (compared with thousands of cases) 4. Simple operation and rapid test, can meet the need of various departments. 5. The effective marker for the early diagnosis of the acute myocardial infraction (AMI) Applicable Departmets: Departments of cardiology, surgery, geriatrics respiratory, obstetrics, pediatrics, emergency ward and ICU.